Abstract
Background. A 15-year-old boy who had been overweight since the age of 6 months was referred to an adolescent obesity clinic for further assessment of his comorbidities and management of his obesity. The patient had no history of developmental delay or abnormal growth velocity. He had previously tested negative for Prader–Willi syndrome and the melanocortin-4 receptor gene mutation. The patient had made numerous attempts at weight loss in the past, but any weight loss he achieved had been temporary. At presentation, the patient had a BMI of 52.3 kg/m2, a waist circumference of 156 cm, blood pressure of 130/85 mmHg and severe acanthosis nigricans in the cervical and axillary skin folds.
Investigations. Measurement of height, weight, waist circumference and blood pressure; screening tests, including a fasting glucose test, 2 h glucose-tolerance test, measurements of blood lipids and liver function tests.
Diagnosis. Morbid obesity, metabolic syndrome, nonalcoholic fatty liver disease, impaired glucose tolerance and dyslipidemia.
Management. The patient was assigned to an extensive lifestyle-modification and behavior-modification program, with clinic-based follow-up every 4 weeks.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Spear, B. A. et al. Recommendations for treatment of child and adolescent overweight and obesity. Pediatrics 120 (Suppl. 4), S254–S288 (2007).
Alberti, K. G., Zimmet, P. & Shaw, J. Metabolic syndrome—a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 23, 469–480 (2006).
Jolliffe, C. J. & Janssen, I. Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation criteria. J. Am. Coll. Cardiol. 49, 891–898 (2007).
Ogden, C. L. et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295, 1549–1555 (2006).
Ogden, C. L., Carroll, M. D. & Flegal, K. M. High body-mass index for age among US children and adolescents, 2003–2006. JAMA 299, 2401–2405 (2008).
Butler, M. G., Theodoro, M. F., Bittel, D. C. & Donnelly, J. E. Energy expenditure and physical activity in Prader–Willi syndrome: comparison with obese subjects. Am. J. Med. Genet. 143, 449–459 (2007).
Farooqi, I. S. et al. Clinical spectrum of obesity and mutations in the melanocortin-4 receptor gene. N. Engl. J. Med. 348, 1085–1095 (2003).
Krebs, N. F. et al. Assessment of child and adolescent overweight and obesity. Pediatrics 120 (Suppl. 4), S193–S228 (2007).
Falkner, B. & Daniels, S. R. Summary of the fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Hypertension 44, 387–388 (2004).
Resnicow, K., Davis, R. & Rollnick, S. Motivational interviewing for pediatric obesity: conceptual issues and evidence review. J. Am. Diet. Assoc. 106, 2024–2033 (2006).
Helsel, D. L., Jakicic, J. M. & Otto, A. D. Comparison of techniques for self-monitoring eating and exercise behaviors on weight loss in a correspondence-based intervention. J. Am. Diet. Assoc. 107, 1807–1810 (2007).
Berkowitz, R. I. et al. Effects of sibutramine treatment in obese adolescents: a randomized trial. Ann. Intern. Med. 145, 81–90 (2006).
Ozkan, B., Bereket, A., Turan, S. & Keskin, S. Addition of orlistat to conventional treatment in adolescents with severe obesity. Eur. J. Pediatr. 163, 738–741 (2004).
Lawson, M. L. et al. One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group. J. Pediatr. Surg. 41, 137–143 (2006).
Holterman, A. X. et al. Short-term outcome in the first 10 morbidly obese adolescent patients in the FDA-approved trial for laparoscopic, adjustable gastric banding. J. Pediatr. Gastroenterol. Nutr. 45, 465–473 (2007).
Acknowledgements
Written consent for publication was obtained from the patient's mother. Charles P Vega, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the Medscape-accredited continuing medical education activity associated with this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kramer, R., Daniels, S. Evaluation of a child for secondary causes of obesity and comorbidities. Nat Rev Endocrinol 5, 227–232 (2009). https://doi.org/10.1038/nrendo.2009.20
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2009.20